Halozyme director Connie Matsui to leave board after nearly 18 years

HALOZYME THERAPEUTICS, INC.

Connie Matsui notified Halozyme on Feb 11, 2025 she will not stand for reelection at the 2025 annual meeting.
Matsui served on the board for nearly 18 years; departure is not due to any disagreement with the company.
No replacement has been announced; the board thanked Matsui for her service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Connie L. Matsui

Director

HALO · HALOZYME THERAPEUTICS, INC.

Filed: February 13, 2025, 6:59 PM ET

On February 11, 2025, Connie L. Matsui, a member of the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”), notified the Company of her intention not to stand for reelection at the Company’s 2025 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Connie L. Matsui departed as Director at HALOZYME THERAPEUTICS, INC..

Action: notified intention not to stand for reelection
Role: Director

Exact text from the filing

On February 11, 2025, Connie L. Matsui, a member of the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”), notified the Company of her intention not to stand for reelection at the Company’s 2025 annual meeting of stockholders.

View on SEC.gov

HALOZYME THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001159036-25-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.